Render Target: STATIC
Render Timestamp: 2025-03-20T10:21:14.727Z
Commit: 779953b12a5930618aae6aca7c87fb286faeb1d7
XML generation date: 2025-03-07 13:20:32.122
Product last modified at: 2025-03-10T20:15:10.314Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

AGPS (F1N3Q) Rabbit mAb #24043

Filter:
  • WB

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 78
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    AGPS (F1N3Q) Rabbit mAb recognizes endogenous levels of total AGPS protein.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu120 of human AGPS protein.

    Background

    Genome-wide CRISPR-Cas9 suppressor screens show that peroxisomes contribute to ferroptosis in human renal and ovarian carcinoma cells by synthesizing polyunsaturated ether phospholipids (PUFA-ePLs). PUFA-ePLs serve as substrates for lipid peroxidation. Genes identified in the screens include those for alkylglycerone phosphate synthase (AGPS) and fatty acyl-CoA reductase 1 (FAR1), two peroxisomal enzymes catalyzing ether lipid biosynthesis. Studies suggest that AGPS and FAR1 contribute to ferroptosis sensitivity (1,2). In addition, research studies show that AGPS suppresses prostate cancer cell proliferation by enhancing ferroptosis (3).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.